Fig. 3
Distribution of projected rotavirus vaccine doses 1 and 2 by sociodemographic disadvantage
Fig. 3 | Cost Effectiveness and Resource Allocation
Distribution of projected rotavirus vaccine doses 1 and 2 by sociodemographic disadvantage